Zerosum™, Inc. is a Pennsylvania USA C Corporation focusing on accelerating the benefits of genetic discoveries and research. Today, the best way to overcome the difficulties associated with advancing genetic solutions to market would be to have an infrastucture that does not rely on legacy operational pathways. This infrastructure should be built based on the latest technology and designed with current and future obejetives in mind. Advances in the life sciences arena are overwhelming existing sytems and resources. Being in it's infancy, the industry offers exciting opportunities but lacks the physical interfaces, global IT infrastructure, and interoperability to a for providing an effective research to market solution.
We believes this problem can be solved and we are developing the results-to-enduser(s) infrastructure required for today's life science advances. The first step is to create a reliable device interface between the rather analog world of life sciences and the digital information world. The second step is connect that conversion interface to our secure BioIT network infrastructure enabling access, storage, and processing directly to the customer.
Current development is focused on the physical device containing the electronics/diagnostic interface(s). Our interface(s) are being designed to be hand-held, field portable, and capable of converting results from our SNP detection module/device. This device then interfaces, either physically or wirelessly, to our network and applications software via our global bioinformatics IT infrastructure.

Companies and consumers, using their respective virtual private newtorks (VPNs), via our BIO Centers infrastructure will be able to:
- access results in a very timely fashion
- rapidly develop, distribute and support software applications
- securely build, access, or expand large databases
- provide genomic information to the end users
and all with a greatly reduced total cost of investment and ownership.